Press Releases :: CV Sciences, Inc. (CVSI)

Investors

Investors

CV Sciences is a consumer wellness company specializing in nutraceuticals and plant-based foods.

Press Releases

CV Sciences Adds +PlusCBD Relief Softgels to Wellness Line of CBD Products

Mar 8, 2022

CV Sciences, Inc. Announces Launch of +PlusCBD™ Pain Relief Topicals

Jan 11, 2022

CV Sciences, Inc. Announces New Distribution Agreement with GNC

Jan 5, 2022

CV Sciences, Inc. Appoints Haskell & White LLP as Auditor

Nov 30, 2021

CV Sciences, Inc. Announces Convertible Note Financing

Nov 15, 2021

CV Sciences, Inc. Reports Third Quarter 2021 Financial Results

Nov 15, 2021

CV Sciences, Inc. to Announce Third Quarter 2021 Results on November 15, 2021

Nov 8, 2021

CV Sciences, Inc. Applauds the California Legislature for Passage of AB 45

Oct 7, 2021

CV Sciences, Inc. Reports Second Quarter 2021 Financial Results

Aug 12, 2021

CV Sciences, Inc. to Announce Second Quarter 2021 Results on August 12, 2021

Aug 5, 2021